de Bruyn, D.P.; Beasley, A.B.; Verdijk, R.M.; van Poppelen, N.M.; Paridaens, D.; de Keizer, R.O.B.; Naus, N.C.; Gray, E.S.; de Klein, A.; Brosens, E.;
et al. Is Tissue Still the Issue? The Promise of Liquid Biopsy in Uveal Melanoma. Biomedicines 2022, 10, 506.
https://doi.org/10.3390/biomedicines10020506
AMA Style
de Bruyn DP, Beasley AB, Verdijk RM, van Poppelen NM, Paridaens D, de Keizer ROB, Naus NC, Gray ES, de Klein A, Brosens E,
et al. Is Tissue Still the Issue? The Promise of Liquid Biopsy in Uveal Melanoma. Biomedicines. 2022; 10(2):506.
https://doi.org/10.3390/biomedicines10020506
Chicago/Turabian Style
de Bruyn, Daniël P., Aaron B. Beasley, Robert M. Verdijk, Natasha M. van Poppelen, Dion Paridaens, Ronald O. B. de Keizer, Nicole C. Naus, Elin S. Gray, Annelies de Klein, Erwin Brosens,
and et al. 2022. "Is Tissue Still the Issue? The Promise of Liquid Biopsy in Uveal Melanoma" Biomedicines 10, no. 2: 506.
https://doi.org/10.3390/biomedicines10020506
APA Style
de Bruyn, D. P., Beasley, A. B., Verdijk, R. M., van Poppelen, N. M., Paridaens, D., de Keizer, R. O. B., Naus, N. C., Gray, E. S., de Klein, A., Brosens, E., & Kiliç, E., on behalf of the Rotterdam Ocular Melanoma Study Group.
(2022). Is Tissue Still the Issue? The Promise of Liquid Biopsy in Uveal Melanoma. Biomedicines, 10(2), 506.
https://doi.org/10.3390/biomedicines10020506
